| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2021 | Aug 18, 2021 | Vistagen Therapeutics, Inc. | PRES./CHIEF SCIENTIFIC OFFICER | Buy | 83.8 | +3,750 | 4.12% | ✗ | $10.2K |
| Nov 20, 2019 | Nov 21, 2019 | Vistagen Therapeutics, Inc. | PRES./CHIEF SCIENTIFIC OFFICER | Buy | 90.0 | +15,000 | 23.91% | ✗ | $5.1K |